Dr Chris Jackson: Cancer researcher says mRNA technology has potential

Hopes our new knowledge of vaccines will help to cure cancer - within the next decade. The founders of BioNTech, who collaborated with Pfizer to create New Zealand's most effective Covid vaccine, are working on an injection to target different types of cancer. It should be available before 2030. The jab uses the same mRNA technology as found in the Covid jab, to assist the immune system to fight off cancer cells. New Zealand cancer researcher Dr Chris Jackson told Mike Hosking the development has potential. LISTEN ABOVESee omnystudio.com/listener for privacy information.